4-139059036-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001331036.3(ELF2):āc.1729A>Gā(p.Ile577Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000613 in 1,613,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001331036.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELF2 | NM_001331036.3 | c.1729A>G | p.Ile577Val | missense_variant | 10/10 | ENST00000686138.1 | NP_001317965.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELF2 | ENST00000686138.1 | c.1729A>G | p.Ile577Val | missense_variant | 10/10 | NM_001331036.3 | ENSP00000510098 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 250982Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135626
GnomAD4 exome AF: 0.0000424 AC: 62AN: 1461570Hom.: 0 Cov.: 31 AF XY: 0.0000481 AC XY: 35AN XY: 727098
GnomAD4 genome AF: 0.000243 AC: 37AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2022 | The c.1693A>G (p.I565V) alteration is located in exon 9 (coding exon 8) of the ELF2 gene. This alteration results from a A to G substitution at nucleotide position 1693, causing the isoleucine (I) at amino acid position 565 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at